medisourceasia.com

Industry News


Home

About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

NIPER Ahmedabad To Collaborate With 2 US-Based Cos Towards Development Of Medical Device Industry

Following its tie-up with Johnson & Johnson and Sahajanand Laser Technologies for development of industry-oriented skilled manpower in the medical device sector, the National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad is planning to collaborate with two US-based companies to equip the students to aggressively take up job roles for the holistic development of domestic industry.

This would also help orient the curriculum of the post graduate studies in medical devices run exclusively at the NIPER Ahmedabad campus towards equipping with the latest updates on technology advancements in the country.

This is a significant milestone as India’s import dependency on high-end medical devices is over 80 per cent and 60 per cent to 70 per cent for other devices. A dedicated medical devices park by the government is also currently in the process of being set-up at Vishakhapatnam which will help in reducing import dependency and increasing export.

Development of domestic industry has gained further impetus as government of India is planning to expand NIPERs across the country to nurture manpower and hence boost domestic manufacturing of medical devices in the country. More than 70 per cent of medical devices are imported as of today which has impacted the development of the domestic industry.

NIPER Ahmedabad had earlier this year signed two MoUs with Johnson & Johnson and Sahajanand Laser Technologies to develop an ecosystem for development of medical devices sector in the country.

As per official sources, a total of 17 MoUs were signed between seven NIPERs and pharma industry for academia industry linkages recently. Academia-industry linkage is a significant development as one of the critical factors in building innovation ecosystem for medical devices industry.

DoP has identified that academia-industry linkage as a basic requirement for translating research into development (commercialisation) and innovation; and also to fix accountability among the educational institutions. Further in India, the research and development in pharmaceuticals sector is spread across a number of ministries and departments viz., department of biotechnology, department of science and technology, department of scientific and industrial research, health systems research (ICMR) and department of pharmaceuticals.

The DoP for the last one year has actively engaged both the NIPERs and the pharma industry to build partnership in areas of education, research and development.

(Ref: http://pharmabiz.com/NewsDetails.aspx?aid=97584&sid=1)


Centre To Establish 3 Mega Industrial Parks In Gujarat For Medical Devices, Bulk Drugs

The Central government will soon establish three mega industry parks in Gujarat which will include a Medical Devices Park, a Pharmaceutical Formulations Park and a Bulk Drugs Park.

Speaking at the inaugural ceremony of the 7th edition of the Pharmac India 2016 held at the Gujarat University Exhibition Hall in Ahmedabad recently, Union minister of chemicals & fertilizers Ananth Kumar put forward a proposal in this regard. The minister offered to develop three pharma sector parks or clusters in Gujarat and promised funds to develop these parks in the state.

”The Centre is ready to give all kind of support to Gujarat if they are ready to start these parks in the state. Each park would require at least 200 acres of land. Central government is ready provide several facilities for these parks, such as effluent treatment plant and roads,” the Union minister said.

Without wasting any time, the Gujarat chief minister Vijaybhai Rupani accepted the Centre’s proposal and said his government would start the work for identifying and acquiring the land for these parks at the earliest. “The state government is very positive about these parks and we will do our best to see that these parks come up at the earliest. These parks are having a huge potential to provide employment opportunity to local youths and make Gujarat a global pharma hub,” Rupani said.

Once in place, these mega parks will reduce the manufacturing cost by 30 to 40 per cent, thus allowing the industry to compete with the world and even with China.

The proposed medical devices park will be the second one in the country similar to the Andhra Medical Technology Park, being set up in Visakhapatnam.

The Centre has planned to develop six pharma clusters in India, where the central government will make the investments and create necessary infrastructure which will include testing facilities, effluent treatment facility, etc.

(Ref: http://www.pharmabiz.com/NewsDetails.aspx?aid=98129&sid=1)

Other News

Sahajanand Medical Technologies Opens New R&D Facility In Ireland

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next